CalciMedica, Inc. financial data

Symbol
CALC on Nasdaq
Location
505 Coast Boulevard South, Suite 307, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
CalciMedica, Inc. /DE/ (to 3/22/2023), GRAYBUG VISION, INC. (to 3/15/2023), GRAYBUG, Inc. (to 5/13/2016), GRAYBUG LLC (to 10/7/2014)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 464 % +15.6%
Debt-to-equity 48.3 %
Return On Equity -98 % -196%
Return On Assets -66.1 % +36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.8M shares +89.9%
Common Stock, Shares, Outstanding 10.8M shares +89.9%
Entity Public Float 11.7M USD -10%
Common Stock, Value, Issued 3K USD +200%
Weighted Average Number of Shares Outstanding, Basic 11.1M shares +96.6%
Weighted Average Number of Shares Outstanding, Diluted 11.1M shares +96.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 12.7M USD -6.06%
General and Administrative Expense 8.79M USD -59.7%
Operating Income (Loss) -21.4M USD +39.3%
Nonoperating Income (Expense) 8.86M USD +3.49%
Income Tax Expense (Benefit) 1K USD 0%
Net Income (Loss) Attributable to Parent -12.6M USD +52.9%
Earnings Per Share, Basic 16.5 USD/shares +67.6%
Earnings Per Share, Diluted 16.5 USD/shares +67.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.06M USD -73.5%
Cash, Cash Equivalents, and Short-term Investments 19.1M USD
Assets, Current 20.4M USD +1.98%
Property, Plant and Equipment, Net 138K USD -30.7%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 21.1M USD +3.99%
Accounts Payable, Current 2.14M USD +23%
Employee-related Liabilities, Current 758K USD -6.77%
Accrued Liabilities, Current 200K USD -34.2%
Liabilities, Current 3.91M USD -2.73%
Operating Lease, Liability, Noncurrent 102K USD
Liabilities 7.21M USD +79.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -9K USD
Retained Earnings (Accumulated Deficit) -150M USD -9.17%
Stockholders' Equity Attributable to Parent 13.8M USD -14.7%
Liabilities and Equity 21.1M USD +3.99%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.72M USD +12%
Net Cash Provided by (Used in) Financing Activities 19M USD -19%
Net Cash Provided by (Used in) Investing Activities -13.1M USD -376%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 10.8M shares +89.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.23M USD -94.7%
Deferred Tax Assets, Valuation Allowance 82.6M USD +192%
Deferred Tax Assets, Gross 82.6M USD +192%
Operating Lease, Liability 117K USD -76.2%
Depreciation 15K USD +7.14%
Payments to Acquire Property, Plant, and Equipment 4K USD -97.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.95M USD +37.4%
Lessee, Operating Lease, Liability, to be Paid 118K USD -76.8%
Operating Lease, Liability, Current 203K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 205K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -94.1%
Deferred Tax Assets, Operating Loss Carryforwards 58.5M USD +270%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 11.1M USD +47.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 13K USD 0%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 118K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 12M USD +759%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%